Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Renal Cell × Cryotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 2 Breast Neoplasms 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pain 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1 Bone Neoplasms 1

Interventions

pembrolizumab 6 Sunitinib 5 Bevacizumab 4 Sorafenib 3 Radiotherapy 3 Radiosurgery 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Interleukin-2 3 Cyclophosphamide 3 Axitinib 3 tivozanib 2 fludarabine phosphate 2 durvalumab 2 avelumab 2 atezolizumab 2 Peripheral Blood Stem Cell Transplantation 2 Optical Imaging 2 Nephrectomy 2 Gene Expression Profiling 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 tremelimumab 1 temsirolimus 1 siltuximab 1 sargramostim 1 pazopanib 1 pamiparib 1 milademetan 1 lenvatinib 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00858975 2013-08-13

Study of Cryotherapy for Renal Tumors

National Taiwan University Hospital

Phase NA Withdrawn

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡